BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
71 results:

  • 1. Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy.
    Yang Z; Wang N; Han R; Tang Y; Chen H; Xie Y; Wang R; Tang L
    Eur J Radiol; 2024 Feb; 171():111294. PubMed ID: 38218065
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancer.
    Lin L; Li H; Wang X; Wang Z; Su G; Zhou J; Sun S; Ma X; Chen Y; You C; Gu Y
    Cancer Med; 2023 Dec; 12(24):21639-21650. PubMed ID: 38059408
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive breast cancer Cells via HDAC4.
    Zhang M; Wang M; Jiang Z; Fu Z; Ma J; Gao S
    Breast J; 2023; 2023():2875972. PubMed ID: 37711168
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with breast cancer.
    Xiong D; Yang J; Li D; Wang J
    Cardiovasc Toxicol; 2023 Oct; 23(9-10):329-348. PubMed ID: 37684436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The expression profiles of signature genes from CD103
    Xia ZA; Lu C; Pan C; Li J; Li J; Mao Y; Sun L; He J
    BMC Med; 2023 Jul; 21(1):268. PubMed ID: 37488535
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative breast cancer Patients.
    Wang X; Wang J; He Y; Li J; Wang T; Ouyang T; Fan Z
    Clin Breast Cancer; 2023 Jun; 23(4):423-430. PubMed ID: 36997401
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Icariin Induces Triple-Negative breast cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway.
    Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
    Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KPT-330 and Y219 exert a synergistic antitumor effect in triple-negative breast cancer through inhibiting NF-κB signaling.
    Wen T; Geng M; Bai E; Wang X; Miao H; Chen Z; Zhou H; Wang J; Shi J; Zhang Y; Lei M; Zhu Y
    FEBS Open Bio; 2023 Apr; 13(4):751-762. PubMed ID: 36847599
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis.
    Li W; Cheng M; Hu P; Jiang L; Zhao X
    Sci Rep; 2023 Jan; 13(1):283. PubMed ID: 36609573
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Noninvasive prediction of axillary lymph node status in breast cancer using promoter profiling of circulating cell-free DNA.
    Guo ZW; Liu Q; Yang X; Cai GX; Han BW; Huang LM; Li CX; Liang ZK; Zhai XM; Lin L; Li K; Zhang M; Liu TC; Pan RL; Wu YS; Yang XX
    J Transl Med; 2022 Dec; 20(1):557. PubMed ID: 36463222
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.
    Zhao M; Pan B; He Y; Niu B; Gao X
    Aging (Albany NY); 2022 Jul; 14(14):5812-5837. PubMed ID: 35859293
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mammographic Density Decline, Tamoxifen Response, and prognosis by Molecular Characteristics of Estrogen Receptor-Positive breast cancer.
    Abubakar M; Mullooly M; Nyante S; Pfeiffer RM; Aiello Bowles EJ; Cora R; Bodelon C; Butler E; Butcher D; Sternberg L; Troester MA; Weinmann S; Sherman M; Glass AG; Berrington de Gonzalez A; Gierach GL
    JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35583138
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role.
    Mulla SW; Venkatraman P
    Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory breast cancer Treated With Trimodality Therapy.
    Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
    Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer.
    Zheng L; He J; Li M; Yuan H; Li H; Hu F; Chen L; Tang W; Sheng M
    Pathol Res Pract; 2022 Mar; 231():153810. PubMed ID: 35182891
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiplexed immunofluorescence identifies high stromal CD68
    Wang J; Browne L; Slapetova I; Shang F; Lee K; Lynch J; Beretov J; Whan R; Graham PH; Millar EKA
    Sci Rep; 2021 Nov; 11(1):21608. PubMed ID: 34732817
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]    [Full Text] [Related]  

  • 18. prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate cancer.
    Aggarwal R; Rydzewski NR; Zhang L; Foye A; Kim W; Helzer KT; Bakhtiar H; Chang SL; Perry MD; Gleave M; Reiter RE; Huang J; Evans CP; Alumkal JJ; Lang JM; Yu M; Quigley DA; Sjöström M; Small EJ; Feng FY; Zhao SG
    JAMA Oncol; 2021 Nov; 7(11):1644-1652. PubMed ID: 34554200
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Holocaust Is a Significant and Independent Risk Factor of Late-Onset cancers: A Systematic Review of the Literature and Original Data on Jewish Israeli, Jewish Non-Israeli and Non-Jewish Non-Israeli Survivors.
    Virgilio E; Camilli D; Gili G; Montali F; Salvemini C; Annicchiarico A; Pagliai L; Morini A; Romboli A; Costi R
    Anticancer Res; 2021 Jun; 41(6):2745-2757. PubMed ID: 34083265
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
    Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
    BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.